Jackson Tang

发表

Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment

S. Sen, A. Díez-Pérez, A. Modi, 2015, Current medical research and opinion.

Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas

K. Iglay, Y. Qiu, P. Laires, 2016, Current medical research and opinion.

Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration

K. Iglay, Y. Qiu, P. Laires, 2017, Expert review of pharmacoeconomics & outcomes research.

Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn’s Disease

P. Atanasov, J. Chao, E. Wu, 2012, PharmacoEconomics.

Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective.

E. Wu, P. Pollack, P. Mulani, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Direct and indirect costs among employees with diabetic retinopathy in the United States.

H. Birnbaum, A. Oglesby, Lauren J. Lee, 2008, Current medical research and opinion.

History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis

Jingbo Yu, A. Modi, S. Sajjan, 2015, International journal of women's health.

Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective.

Shaloo Gupta, H. Costantino, A. Kulasekararaj, 2020, Cancer reports.

PGI13 LOWER DISEASE ACTIVITY AND CLINICAL REMISSION ARE ASSOCIATED WITH REDUCED HOSPITALIZATION RISK IN CROHN'S DISEASE

P. Atanasov, E. Wu, P. Pollack, 2007 .

Physicians’ experience in blood supply shortages and the top factors that impact the clinical, economic, and humanistic outcomes of patients with myelodysplastic syndromes in 5 European countries

Shaloo Gupta, H. Costantino, A. Kulasekararaj, 2022, Current medical research and opinion.

E. Krishnan, E. Wu, A. Yu, 2008, Journal of managed care pharmacy : JMCP.

Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta‐thalassemia in Taiwan: A real‐world analysis

C. Tang, K. Musallam, Jackson Tang, 2021, Transfusion.

Analytic models to identify patients at risk for prescription opioid abuse.

Matt Schiller, Alan G. White, A. White, 2009, The American journal of managed care.

Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients

A. Tarhini, Jackson Tang, Jeetvan G Patel, 2022, Melanoma research.

Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly.

Zhiyi Li, Jackson Tang, S. Ghate, 2018, American health & drug benefits.

Costs associated with adverse events for systemic therapies in metastatic melanoma.

A. Fu, Y. Qiu, Zhiyi Li, 2018, Journal of comparative effectiveness research.

Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy

S. Sen, E. Siris, A. Modi, 2015, Current medical research and opinion.

Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review

Jingbo Yu, Dilan Paranagama, A. Naim, 2022, Bone Marrow Transplantation.

A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices

Jingbo Yu, Dilan Paranagama, Jackson Tang, 2022, Acta Haematologica.

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

M. Dimopoulos, C. Yip, J. San-Miguel, 2021, HemaSphere.

Antidepressant treatment patterns and costs among US employees

H. Birnbaum, P. Greenberg, R. Ben-Hamadi, 2009, Journal of medical economics.

Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons

R. Ben-Hamadi, E. Wu, A. Yu, 2010, Journal of medical economics.

Gastrointestinal events and association with initiation of treatment for osteoporosis

S. Sen, E. Siris, A. Modi, 2015, ClinicoEconomics and outcomes research : CEOR.

Frequency, Risk, and Cost of Gout-related Episodes Among the Elderly: Does Serum Uric Acid Level Matter?

E. Krishnan, E. Wu, A. Yu, 2009, The Journal of Rheumatology.

Economic burden of psoriasis compared to the general population and stratified by disease severity

Jipan Xie, E. Wu, Y. Bao, 2009, Current medical research and opinion.

Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis

S. Sen, E. Siris, A. Modi, 2014, Current medical research and opinion.

Employees With Fibromyalgia: Medical Comorbidity, Healthcare Costs, and Work Loss

H. Birnbaum, R. Robinson, L. White, 2008, Journal of occupational and environmental medicine.

NE1 EMPLOYEES WITH FIBROMYALGIA: MEDICAL COMORBIDITY, HEALTH CARE COSTS, AND WORK LOSS

H. Birnbaum, R. Robinson, L. White, 2007 .

Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study

Jingbo Yu, Dilan Paranagama, A. Naim, 2022, Bone Marrow Transplantation.

Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis

B. Cortet, A. Modi, S. Sajjan, 2016, BMC Musculoskeletal Disorders.

Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: An observational study

A. Modi, S. Sajjan, J. Weaver, 2016, Bone reports.

Why physicians do not initiate dual therapy as recommended by AACE guidelines: A survey of clinicians in the United States.

R. Shankar, Y. Qiu, S. Engel, 2015, Diabetes research and clinical practice.

Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants

H. Birnbaum, P. Greenberg, R. Ben-Hamadi, 2012, PharmacoEconomics.

Direct and indirect costs among employees with diabetic retinopathy in the United States*

H. Birnbaum, A. Oglesby, A. Yu, 2008 .

Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment

S. Sen, A. Díez-Pérez, A. Modi, 2015, Current medical research and opinion.